The program is still filling in: most podium sessions list one speaker so far, and 228 people on the speaker list have no session yet. We’ll add their talks and organizations as SLAS publishes them.

Biopharma and crop-science companies at SLAS2027

Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website

34 biopharma and crop-science companies are at SLAS2027 — 31 presentations on the program. Most represented: AstraZeneca (16 on the program), GSK (8 on the program), Genentech (4 on the program). 16 of them have their own page in this guide. As of Oct 17, 2026.

All 542 organizations at SLAS2027 →

Showing 1–16 of 34 organizations

Organization	SLAS2027 Attendance
AstraZeneca Cambridge, UK
astrazeneca.com Biopharma Biopharmaceutical company developing medicines in oncology, rare disease, cardiovascular, renal, metabolic and respiratory disease.	Workshop Sat Jan 30 8:30am–4:30pm Genome Editing and AI-Driven Approaches in Drug Discovery and Target Validation Room 8 Assay development and screening Workshop Sun Jan 31 8:30am–12pm Operationalizing DMTA: From Implementation to Continuous Optimization Room 1B Automation and robotics Workshop Sun Jan 31 8:30am–4:30pm An Introduction to Mass Spectrometry and its Applications within Drug Discovery Room 11B Assay development and screening Session Mon Feb 1 10am–12pm Advanced Imaging & Phenotypic Screening Ballroom 6D Assay development and screening 10amA Multimodal Perturbation Atlas Defines the Phenotypic Resolution of Cellular Morphology 10:30amPhenotypic profiling reveals targets impacting mitochondrial dysfunction in COPDAstraZeneca 11amLive FluoroSpot: Real-Time Imaging of Single-Cell Secretion Dynamics for Functional ScreeningThe University of Tokyo 11:30amAutomated Screening of Antibiotic Combination and Sequence Effects via a Multiplexed Microfluidic PlatformUniversity of Chicago Talk Mon Feb 1 10:30–10:55am Part of Advanced Imaging & Phenotypic Screening Phenotypic profiling reveals targets impacting mitochondrial dysfunction in COPD Ballroom 6D Assay development and screening Session Mon Feb 1 2–2:45pm Encoded Libraries and Biophyscial Lead Discovery Ballroom 6F Assay development and screening Session Tue Feb 2 3–5pm Emerging Assays and Screening Technology Ballroom 6D Assay development and screening Also Presenting at the meeting, beyond the sessions above
GSK London, UK
gsk.com Biopharma Biopharmaceutical company developing vaccines and medicines in infectious disease, HIV, respiratory, immunology and oncology.	Session Mon Feb 1 10am–12pm People at the Heart of Lab Automation: Building Skills, Careers, and Adoption Ballroom 6F Automation and robotics Session Mon Feb 1 3–5pm ADMET Automation Success and Innovation Ballroom 6F Automation and robotics Session Tue Feb 2 10am–12pm Sample Management Room 8 Sample management and tracking Session Tue Feb 2 1–1:45pm Proximity Assays Room 7AB Assay development and screening Session Tue Feb 2 3–5pm Automation Technology to Maximize Lead Optimization of Antibodies, Biologics and Synthetic Peptides Ballroom 6F Automation and robotics 3:30pmTalk, title to be announced Also Presenting at the meeting, beyond the sessions above
Genentech South San Francisco, CA
gene.com Biopharma Biotechnology company and member of the Roche Group, discovering and developing medicines for serious diseases.	Session Mon Feb 1 3–5pm Beyond Dose-Response - Perturbation Screens to Uncover Drug Effects in Patient-Derived Cells Room 7AB Cell culture and 3D models Session Tue Feb 2 10am–12pm Automation Technology to Maximize Organic Chemistry Synthesis Ballroom 6F Automation and robotics Session Tue Feb 2 2–2:45pm Sample Management Ballroom 6C Sample management and tracking Also Presenting at the meeting, beyond the sessions above
Bristol Myers Squibb Princeton, NJ
bms.com Biopharma Biopharmaceutical company developing medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience.	Workshop Sat Jan 30 8:30am–4:30pm Introduction to Lab Automation Room 1B Automation and robotics Also Presenting at the meeting, beyond the sessions above
Recursion Salt Lake City, UT
recursion.com Biopharma Biotech combining automated biology, cellular imaging and machine learning to discover medicines.	Session Mon Feb 1 10am–12pm Mechanistic and Causal AI: From Predictive Patterns to Prescriptive Discovery Ballroom 6C Software, data and AI Talk Wed Feb 3 3–3:25pm Part of Enabling the Connection Between Automation Processes/ Platforms for Target Candidate Profile Why we automated DMTL. And why you should too. Ballroom 6F Automation and robotics Also Presenting at the meeting, beyond the sessions above
Calico Life Sciences South San Francisco, CA
calicolabs.com Biopharma Alphabet-founded research company studying the biology of aging to develop medicines for age-related diseases.	Talk Wed Feb 3 1:30–1:55pm Part of Enabling the Connection Between Automation Processes/ Platforms for Target Candidate Profile Automation for the in vitro assay cascade at Calico Ballroom 6F Automation and robotics Also Presenting at the meeting, beyond the sessions above
AbbVie North Chicago, IL
abbvie.com Biopharma Biopharmaceutical company developing medicines in immunology, oncology, neuroscience and eye care.	Also Presenting at the meeting, on no published session yet
Gilead Sciences Foster City, CA
gilead.com Biopharma Biopharmaceutical company developing medicines in HIV, liver disease, oncology and inflammation.	Also Presenting at the meeting, on no published session yet
Eli Lilly and Company Indianapolis, IN
lilly.com Biopharma Pharmaceutical company developing medicines in diabetes, obesity, oncology, immunology and neuroscience.	Workshop Sat Jan 30 8:15am–5pm Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Room 3 Assay development and screening Session Tue Feb 2 10am–12pm AI for Assay Development and Prediction Ballroom 6D Assay development and screening 10:30amFrom Brightfield Images to Phenotypic Insight: An AI-Based Pipeline for In Vitro Screening
Pfizer New York, NY
pfizer.com Biopharma Pharmaceutical company developing medicines and vaccines in oncology, inflammation, rare disease and infectious disease.	Session Mon Feb 1 10am–12pm Expanding Induced Proximity Paradigms Beyond Traditional Targeted Protein Degradation (TPD) Ballroom 6E New modalities Session Mon Feb 1 2–2:45pm Encoded Libraries and Biophyscial Lead Discovery Ballroom 6F Assay development and screening
Amgen Thousand Oaks, CA
amgen.com Biopharma Biotechnology company developing medicines for cardiovascular disease, cancer, inflammation and bone health.	Also Presenting at the meeting, on no published session yet
Merck & Co. Rahway, NJ
merck.com Biopharma Pharmaceutical company, known as MSD outside the US and Canada, developing medicines and vaccines.	Also Presenting at the meeting, on no published session yet
Roche Basel, Switzerland
roche.com Biopharma Healthcare company developing pharmaceuticals and diagnostics.	Also Presenting at the meeting, on no published session yet
C4 Therapeutics Watertown, MA
c4therapeutics.com Biopharma Biotech developing targeted protein degrader medicines for cancer.	Session Mon Feb 1 2–2:45pm ADMET Room 7AB Assay development and screening
FMC Corporation Philadelphia, PA
fmc.com Biopharma Agricultural sciences company developing crop protection products.	Session Mon Feb 1 2–2:45pm Automation and Screening in Agri-Tech Ballroom 6C Automation and robotics · Assay development and screening
Neomorph San Diego, CA
neomorph.com Biopharma Biotech developing molecular glue degraders that direct disease-causing proteins for destruction.	Session Tue Feb 2 10am–12pm Harnessing Machine Learning and Generative AI to Transform Therapeutic Discovery and Design Ballroom 6E New modalities 10:30amBuilding AI/ML-Ready Multimodal Data Resources at Scale

Instantly find 20 buyers from biopharma and crop-science companies

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction

Instantly find 20 buyers from biopharma and crop-science companies

Browse SLAS2027 by